Sitagliptin Phosphate is a DPP-4 inhibitor used to improve glycemic control in type 2 diabetes patients.
Sitagliptin phosphate belongs to a class of medicines called DPP-4 inhibitors. It is used mainly to lower high blood-sugar levels in people with type 2 diabetes. In Hong Kong, sitagliptin phosphate is found in products such as Januvia and the generic tablet Sitagliptin.
In the local market, two common oral tablets contain sitagliptin phosphate. Januvia is the brand name marketed by Merck, while Sitagliptin is the generic version sold by several pharmaceutical companies. Both are supplied as film-coated tablets, typically in strengths of 25 mg, 50 mg or 100 mg. They are taken by mouth and are listed on the Hong Kong Medicines Registry. The tablets are plain or white, and the packaging follows the Department of Health’s labelling guidelines. Whether you obtain a branded or generic product, the active ingredient and its intended effect are the same.
Sitagliptin is generally considered for adults whose diabetes is not adequately managed by lifestyle changes alone. It is not indicated for type 1 diabetes or for treating high blood sugar caused by other conditions.
Sitagliptin phosphate blocks an enzyme called DPP-4. This enzyme normally degrades hormones known as incretins, which are released after meals. By inhibiting DPP-4, sitagliptin allows incretins to remain active longer, helping the pancreas release more insulin when blood sugar is high and reducing the amount of glucose produced by the liver. The result is a gradual lowering of blood-sugar levels, usually noticeable within a few weeks of regular use.
Most people notice only mild, short-lasting effects. These can include headache, upper-respiratory tract infection, or a feeling of tiredness. Some individuals report stomach discomfort, nausea or occasional joint pain. When these symptoms appear, they often resolve on their own without medical intervention.
Although rare, certain reactions need urgent attention. Signs such as severe rash, swelling of the face or lips, difficulty breathing, or a sudden drop in blood pressure may indicate an allergic response. If any of these occur, seek immediate medical help.
People with a known allergy to sitagliptin phosphate or any of its tablet ingredients should avoid it. Those with a history of pancreatitis, severe kidney impairment, or certain heart conditions should discuss the medication with a health-care professional before starting. Pregnant or breastfeeding individuals should also obtain professional guidance, as the safety profile in these groups is not fully established.
Sitagliptin phosphate can interact with other medicines that affect blood sugar, such as insulin or sulfonylureas, potentially increasing the risk of low blood glucose. Alcohol consumption may also enhance hypoglycaemic effects when combined with certain diabetes drugs. Some antibiotics, anti-inflammatory agents and certain cholesterol-lowering medicines have been reported to influence the way sitagliptin works. For a complete list of possible interactions, refer to the specific product’s information sheet.
Store tablets in a cool, dry place away from direct sunlight and out of reach of children. The usual treatment course is long-term, as type 2 diabetes is a chronic condition, but the exact duration depends on individual health goals and the specific product used. Always read the patient information leaflet that accompanies Januvia or the generic Sitagliptin tablet, and follow the directions given by your health-care provider. For detailed usage, dosing, administration, and monitoring, refer to the individual medication’s information.
DPP-4 inhibitor: A drug that blocks the enzyme dipeptidyl-peptidase-4, helping to keep blood-sugar-lowering hormones active.
Incretin: Hormones released after eating that stimulate insulin release and lower blood glucose.
Glycaemic stability: Keeping blood-sugar levels within a healthy range over time.
This article offers general educational information about sitagliptin phosphate as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing sitagliptin phosphate may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your health-care provider’s guidance for complete information on proper use, dosage, and safety.
